Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Sarcoma, Ewing × thymoglobulin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myelodysplastic Syndromes 39 Leukemia, Myeloid, Acute 39 Leukemia 29 Precursor Cell Lymphoblastic Leukemia-Lymphoma 28 Lymphoma, Non-Hodgkin 26 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 24 Hodgkin Disease 22 Leukemia, Lymphocytic, Chronic, B-Cell 21 Lymphoma 20 Hematologic Neoplasms 20 Multiple Myeloma 17 Myeloproliferative Disorders 13 Graft vs Host Disease 13 Primary Myelofibrosis 12 Leukemia, Myelomonocytic, Juvenile 10 Lymphoma, Large B-Cell, Diffuse 8 Lymphoma, Mantle-Cell 7 Lymphoma, Follicular 7 Lymphoma, B-Cell, Marginal Zone 7 Leukemia, Myelomonocytic, Chronic 7 Lymphoma, Large-Cell, Immunoblastic 6 Leukemia, Myeloid, Accelerated Phase 6 Congenital Abnormalities 6 Burkitt Lymphoma 6 Waldenstrom Macroglobulinemia 5 Neuroblastoma 5 Lymphoma, T-Cell, Cutaneous 5 Leukemia, Myeloid, Chronic-Phase 5 Blast Crisis 5 Recurrence 4

Interventions

Cyclophosphamide 15 Temozolomide 12 Vincristine 9 Irinotecan 8 Melphalan 7 Doxorubicin 7 Topotecan 6 Granulocyte Colony-Stimulating Factor 6 Busulfan 6 Etoposide 5 Drug Therapy 5 liposomal doxorubicin 4 fludarabine 4 cabozantinib 4 Sirolimus 4 Ifosfamide 4 Filgrastim 4 pegfilgrastim 3 fludarabine phosphate 3 Zoledronic Acid 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Cisplatin 3 Bone Marrow Transplantation 3 regorafenib 2 pegylated granulocyte colony-stimulating factor 2 olaparib 2 irinotecan sucrosofate 2 ganitumab 2 Vinorelbine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02472392 2017-05-09

Ewing/Allo

University of Louisville

Phase 1 Completed

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡